Physician profile
Nidhi Tripathi
NPI 1083956692
$3,012.98
in general payments reported to CMS, 2019-2025
21 companies · $27.76 in 2025
The $27.76 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $357 · 2021: $522 · 2022: $916 · 2023: $698 · 2024: $338 · 2025: $27.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $406.36 | 2020-2024 | Camzyos, Eliquis |
| Novo Nordisk INC | $402.96 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Amgen INC. | $328.56 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $257.29 | 2020-2023 | Lokelma |
| Novartis Pharmaceuticals Corporation | $256.63 | 2021-2023 | |
| Cvrx, INC. | $216.35 | 2021-2022 | |
| Abbott Laboratories | $174.81 | 2020-2024 | Aveir |
| Amarin Pharma, INC. | $161.38 | 2019-2022 | |
| Pfizer INC. | $148.48 | 2019-2024 | |
| Boston Scientific Corporation | $146.31 | 2022-2023 | Watchman |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.26 | 2020-2023 | Jardiance |
| Medtronic Vascular, INC. | $96.87 | 2019 | |
| Merck Sharp & Dohme LLC | $72.96 | 2021-2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $52.20 | 2021-2024 | Xarelto |
| Irhythm Technologies, INC. | $32.07 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bracco Diagnostics INC. | $27.76 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $27.09 | 2022 | |
| Philips North America LLC | $21.15 | 2023 | |
| Sanofi-Aventis U.S. LLC | $18.42 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.07 | 2024 | Lifevest |
| Medicure Pharma INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nidhi Tripathi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.